Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis
- PMID: 17476275
- DOI: 10.1038/sj.leu.2404730
Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis
Similar articles
-
Concomitant BCR-ABL1 translocation and JAK2(V617F) mutation in three patients with myeloproliferative neoplasms.Diagn Mol Pathol. 2012 Sep;21(3):176-83. doi: 10.1097/PDM.0b013e318246975e. Diagn Mol Pathol. 2012. PMID: 22847163
-
Myeloproliferative disorders with coexisting BCR-ABL translocation and JAK2(V617F) mutation.Leukemia. 2007 Sep;21(9):2051; author reply 2052. doi: 10.1038/sj.leu.2404825. Epub 2007 Jun 28. Leukemia. 2007. PMID: 17597806 No abstract available.
-
JAK2 V617F mutation positive primary myelofibrosis with concomitant t(9;11;22)(q34;p15;q11.2) but no BCR/ABL fusion.Int J Hematol. 2013 Mar;97(3):435-7. doi: 10.1007/s12185-013-1287-y. Epub 2013 Feb 7. Int J Hematol. 2013. PMID: 23389763 No abstract available.
-
Myeloproliferative neoplasms 2012: the John M. Bennett 80th birthday anniversary lecture.Leuk Res. 2012 Dec;36(12):1481-9. doi: 10.1016/j.leukres.2012.08.011. Epub 2012 Aug 21. Leuk Res. 2012. PMID: 22917768 Review.
-
JAK2 V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms.Expert Rev Hematol. 2010 Jun;3(3):323-37. doi: 10.1586/ehm.10.28. Expert Rev Hematol. 2010. PMID: 21082983 Review.
Cited by
-
A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders.Int J Hematol. 2010 Jan;91(1):136-9. doi: 10.1007/s12185-009-0471-6. Epub 2010 Jan 5. Int J Hematol. 2010. PMID: 20047097
-
Clinical, morphological and genetic characteristics of patients with concurrent presence of JAK2 V617F and BCR::ABL1.Sci Rep. 2025 Jul 18;15(1):26046. doi: 10.1038/s41598-025-11096-6. Sci Rep. 2025. PMID: 40681596 Free PMC article.
-
Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination.Front Oncol. 2024 Jan 12;13:1329298. doi: 10.3389/fonc.2023.1329298. eCollection 2023. Front Oncol. 2024. PMID: 38282677 Free PMC article. Review.
-
ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia.Leukemia. 2022 Sep;36(9):2242-2249. doi: 10.1038/s41375-022-01648-4. Epub 2022 Jul 28. Leukemia. 2022. PMID: 35902731 Free PMC article.
-
Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group.Mod Pathol. 2018 May;31(5):690-704. doi: 10.1038/modpathol.2017.182. Epub 2018 Jan 12. Mod Pathol. 2018. PMID: 29327708 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous